{
    "id": "34a3c7b1-c0b3-f667-e063-6294a90aa927",
    "indications": "meclizine hydrochloride tablets indicated treatment vertigo associated diseases affecting vestibular system .",
    "contraindications": "recommended dose 25 100 mg daily administered orally , divided , depending upon response .",
    "warningsAndPrecautions": "meclizine hydrochloride tablets , usp available following strengths package sizes : 25 mg ( yellow , oval shaped tablets , debossed “ tl 121 ” score one side plain side . ) ndc : 70518-1308-00 ndc : 70518-1308-01 ndc : 70518-1308-02 ndc : 70518-1308-03 ndc : 70518-1308-04 ndc : 70518-1308-05 packaging : 90 1 bottle plastic packaging : 30 1 bottle plastic packaging : 60 1 bottle plastic packaging : 21 1 bottle plastic packaging : 6 1 bottle plastic packaging : 10 1 bottle plastic store 20 25°c ( 68 77°f ) [ usp controlled room temperature ] . dispense tight , light-resistant container ( usp ) . keep medication reach children . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "meclizine hydrochloride tablets contraindicated individuals shown previous hypersensitivity .",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "ALUMINUM OXIDE",
            "code": "LMI26O6933"
        },
        {
            "name": "MECLIZINE HYDROCHLORIDE",
            "code": "HDP7W44CIO"
        }
    ],
    "organization": "REMEDYREPACK INC.",
    "name": "MECLIZINE HYDROCHLORIDE",
    "effectiveTime": "20250508",
    "indications_original": "Meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system.",
    "contraindications_original": "The recommended dose is 25 to 100 mg daily administered orally, in divided dosage, depending upon clinical response.",
    "warningsAndPrecautions_original": "Meclizine hydrochloride tablets, USP are available in the following strengths and package sizes:\n                  \n                  25 mg (Yellow, oval shaped tablets, debossed with “TL 121” with score on one side and plain on the other side.)\n                  NDC: 70518-1308-00\n                  NDC: 70518-1308-01\n                  NDC: 70518-1308-02\n                  NDC: 70518-1308-03\n                  NDC: 70518-1308-04\n                  NDC: 70518-1308-05\n                  \n                  \n                  \n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  PACKAGING: 30 in 1 BOTTLE PLASTIC\n                  PACKAGING: 60 in 1 BOTTLE PLASTIC\n                  PACKAGING: 21 in 1 BOTTLE PLASTIC\n                  PACKAGING: 6 in 1 BOTTLE PLASTIC\n                  PACKAGING: 10 in 1 BOTTLE PLASTIC\n                  \n                  \n                  \n                  \n                  \n                     Store at 20 to 25°C (68 to 77°F) [See USP Controlled Room Temperature].\n                  \n                  Dispense in a tight, light-resistant container (USP).\n                  \n                  \n                     Keep this and all medication out of the reach of children.\n                  \n                  \n                  \n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Meclizine hydrochloride tablets are contraindicated in individuals who have shown a previous hypersensitivity to it."
}